Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gut hormones, growth and malignancy

G S Baldwin1, R H Whitehead

  • 1Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria, Australia.

Bailliere'S Clinical Endocrinology and Metabolism
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery.

Nature microbiology·2022
Same author

Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer.

Oncogene·2014
Same author

A MALIGNANT TERATOMA OF THE PERINEUM.

The Journal of experimental medicine·2009
Same author

Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS:gelsolin complex.

Oncogene·2006
Same author

Divergent roles for ferric ions in the biological activity of amidated and non-amidated gastrins.

The Journal of endocrinology·2004
Same author

Over-expression of cyclin D1 regulates Cdk4 protein synthesis.

Cell proliferation·2004

Growth factors like epidermal growth factor (EGF) and gastrin influence gastrointestinal mucosa and cancer growth. Research explores their roles in gastrointestinal carcinomas, suggesting potential therapeutic targets.

Area of Science:

  • Gastroenterology
  • Oncology
  • Molecular Biology

Background:

  • Polypeptide growth factors regulate normal gastrointestinal mucosa proliferation.
  • Epidermal growth factor (EGF) promotes gastrointestinal growth and ulcer healing.
  • Gastrin's primary target is enterochromaffin-like cells; other hormones like FGF and IGFs also show proliferative effects.

Purpose of the Study:

  • To investigate the role of growth factors in gastrointestinal mucosa and carcinoma proliferation.
  • To explore the impact of gastrin and EGF on various gastrointestinal cancers.
  • To identify potential therapeutic strategies targeting growth factor pathways in gastrointestinal cancers.

Main Methods:

  • Review of existing evidence on growth factor effects on gastrointestinal mucosa and carcinomas.

Related Experiment Videos

  • Analysis of in vivo and in vitro studies involving growth factors and cancer cell lines.
  • Examination of autocrine stimulation mechanisms in gastrointestinal carcinomas.

    • Main Results:

    • EGF stimulates normal gastrointestinal growth and proliferation of many gastrointestinal cancer cell lines in vitro.
    • Gastrin stimulates in vivo growth of some gastric and colorectal xenografts but not cell lines in vitro.
    • Elevated EGF receptor and mRNA levels are found in gastric carcinomas, with EGF pathway inhibition showing anti-proliferative effects.

    Conclusions:

    • Growth factors play a significant role in both normal gastrointestinal tissue and cancer.
    • EGF is a key mitogen for gastrointestinal cancer cells, suggesting its potential as a therapeutic target.
    • Gastrin/cholecystokinin antagonists may offer novel therapeutic avenues for gastrointestinal cancers.